Cardica's Automated Anastomosis Systems Featured at Advances In Robotic And Hybrid Coronary Revascularization Meeting

Oct 27, 2010, 08:00 ET from Cardica, Inc.

REDWOOD CITY, Calif, Oct. 27/PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that its C-Port® Flex-A® Anastomosis System and its PAS-Port® Proximal Anastomosis System will be featured in several demonstration and wet lab presentations at the Advances in Robotic and Hybrid Coronary Revascularization conference, a meeting jointly developed by the International College of Robotic Surgery and Saint Joseph's Hospital in Atlanta, Georgia.

"This inaugural meeting will host more than 100 cardiothoracic surgeons from around the world, and is the first of its kind," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica. "We congratulate the presenting surgeons, who continue to push the envelope and remain on the leading edge of cardiothoracic surgery, and commend the cardiothoracic surgeons and specialists attending the meeting, who are advancing their capabilities in minimally invasive cardiothoracic surgery. This forum represents an ideal interchange to advance the field of less invasive cardiac surgery."

The Cardica automated anastomosis systems will be featured in the presentations as follows:

  • Beating Heart Totally Endoscopic Coronary Artery Bypass (BH TECAB) with Flex-A Automated Anastomosis Connector, Friday, October 29, 2010 8:40 a.m. to 9:30 a.m.
  • Conduits and Multivessel TECAB, Friday October 29, 2010, 1:20 p.m. to 2:50 p.m.
  • Troubleshooting, Friday, October 29, 2010, 3:10 p.m. to 4:30 p.m.
  • Hands-on Wet Lab, Saturday, October 30, 2010 8:40 a.m. to 12:40 p.m.

To view a presentation showing Dr. Husam Balkhy completing a BH TECAB, please visit http://www.cardica.com/presentations/bhtecab/player.html. Cardica's C-Port® Distal Anastomosis and PAS-Port® Proximal Anastomosis Systems automate the connection of blood vessels (known as anastomoses) during CABG surgery, replacing hand-sewn sutures. The reliable, automated connection of the vessels is particularly useful for accessing difficult to reach targets. Anastomoses are often considered the most critical step of the bypass procedure. Cardica's PAS-Port proximal system attaches the bypass graft to the aorta, upstream of the occlusion, while Cardica's C-Port® Distal Anastomosis Systems connect the bypass grafts to coronary arteries downstream of the occlusion. A triple bypass procedure, for example, requires up to five anastomoses. Now, in many instances, all connections could be performed using Cardica's PAS-Port and C-Port anastomosis systems. Cardica is a co-sponsor of the conference.

About Cardica

Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and endoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System, for CABG surgery and has shipped over 30,000 units throughout the world. In addition, Cardica is developing the Cardica Microcutter ES8, a true multi-fire endoscopic stapling device designed to be used in a variety of procedures, including bariatric, thoracic and general surgery. The Cardica Microcutter ES8 requires regulatory clearance through the 510(k) or other process with the U.S. Food & Drug Administration and is not yet commercially available.

Forward-Looking Statements

This press release contains "forward-looking" statements, including all statements regarding the potential benefits of using Cardica's proximal and distal anastomosis systems. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "could," "intended," "designed" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including that Cardica's current and any future products may never gain any significant degree of market acceptance, as well as other risks detailed from time to time in Cardica's reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.

SOURCE Cardica, Inc.



RELATED LINKS

http://www.cardica.com